SCHEMBL6206684

SCHEMBL6206684

CCC(NC(=O)CC1CCCCC1)C(O)c1nc2ccccc2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
EPHX2 P34913 2/20 0.39
CTSS P25774 4/20 0.38
P2RX7 Q99572 2/20 0.38
FAAH O00519 1/20 0.38
LMNA P02545 2/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5946008 0.84 CTSS (0.42) NPC1RAB9ACTSS
SCHEMBL6206683 0.83 FAAH (0.44) NPC1RAB9ASMN1; SMN2CTSSFAAH
SCHEMBL6206918 0.82 METAP2 (0.40) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL14974258 0.80 PTPN2 (0.41) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5945973 0.78 CTSS (0.34) NPC1RAB9ACTSSTSHR
SCHEMBL5945990 0.77 CTSS (0.40) CTSS
SCHEMBL5945985 0.77 CTSS (0.40) CTSS
SCHEMBL6463649 0.77 MEN1 (0.40) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6473321 0.77 MEN1 (0.40) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5946098 0.77 CTSS (0.40) CTSSFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1503997-A1 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-02-09 EP disclosed
WO-2003097617-A1 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-11-27 WO disclosed